The Desmond Tutu HIV Centre at the University of Cape Town is delighted and relieved that the Dapivirine vaginal ring has been approved by the European Medicines Agency. Research has shown that the vaginal ring reduces the chances of HIV transmission by 35% in women. #sabcnews — SAfm news (@SAfmnews) July 25, 2020  ICWEA, Advocates for the prevention of HIV in Africa & Emthonjeni welcome with great news of on the dapivirine vaginal ring for use by cisgender to reduce the risk of HIV-1 infection.
Dapivirine Ring could give African women their first long-acting HIV prevention option! pic.twitter.com/2TL8VcAy28 — ICWEA (@ICWEastAfrica) July 24, 2020  The related video below has more on the vaginal ring: 